Federation des caisses Desjardins du Quebec’s Tonix Pharmaceuticals TNXP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TNXP Stock Details TNXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.49K	Hold	108	–	–	﹤0.01%	2711
2025 Q4	$1.68K	Sell	108 -87	-45%	-$1.6K	﹤0.01%	2621
2025 Q3	$4.71K	Buy	195 +165	+550%	+$6.12K	﹤0.01%	2472
2025 Q2	$1.08K	Buy	+30	New	+$786	﹤0.01%	2495
2025 Q1	–	Hold	0	–	-$1	–	2759
2024 Q4	–	Hold	0	–	–	–	2552
2024 Q3	–	Hold	0	–	–	–	2701
2024 Q2	–	Hold	0	–	-$5	–	2570
2024 Q1	–	Hold	0	–	–	–	2397
2023 Q4	–	Hold	0	–	–	–	2359
2023 Q3	–	Hold	0	–	–	–	2377
2023 Q2	–	Hold	0	–	–	–	2297
2023 Q1	–	Hold	0	–	–	–	2284
2022 Q4	–	Hold	0	–	–	–	2438
2022 Q3	–	Hold	0	–	–	–	2472
2022 Q2	–	Hold	0	–	–	–	2477
2022 Q1	–	Hold	0	–	–	–	2417
2021 Q4	–	Hold	0	–	–	–	2371
2021 Q3	–	Hold	0	–	–	–	2355
2021 Q2	–	Hold	0	–	–	–	2203
2021 Q1	–	Hold	0	–	–	–	2128
2020 Q4	–	Hold	0	–	–	–	2152
2020 Q3	–	Hold	0	–	–	–	1703
2020 Q2	–	Hold	0	–	–	–	1891
2020 Q1	–	Hold	0	–	–	–	1898

Other funds holding TNXP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TNXP Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec held its Tonix Pharmaceuticals (TNXP) position steady in Q1 2026 at 108 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

Federation des caisses Desjardins du Quebec first reported a position in TNXP in Q2 2025 and has held it in 4 quarters since. The position peaked at $4.71K in Q3 2025. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

Federation des caisses Desjardins du Quebec held 108 shares of Tonix Pharmaceuticals worth $1.49K as of Q1 2026.
Federation des caisses Desjardins du Quebec left its Tonix Pharmaceuticals share count unchanged in Q1 2026.
Tonix Pharmaceuticals made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2711 holding.
Federation des caisses Desjardins du Quebec first reported a position in Tonix Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
Federation des caisses Desjardins du Quebec's Tonix Pharmaceuticals position peaked at $4.71K in Q3 2025.
81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.